Catalyst Event
Recursion Pharmaceauticals Inc (RXRX) · Earnings Release
From KEDI U.S. Medical AI Index (KUSMAI)
5/4/2026, 12:00:00 AM
Recursion is scheduled to report Q1 2026 financial results on May 4, 2026; analysts forecast an EPS of approximately -$0.27 and revenue of $17.46 million, forecasted. Medium importance is estimated as earnings reports typically drive significant price movement.
Korean Translation
2026년 5월 4일 2026년 1분기 재무 실적 발표 예정임. 분석가들은 주당순이익(EPS) 약 -0.27달러, 매출 1,746만 달러를 기록할 것으로 전망됨. 실적 발표는 통상적으로 주가 변동성을 유발하므로 중요도를 'Medium'으로 예상함.
Related Recent Events
NVIDIA Corporation (NVDA) · Earnings Release
NVIDIA's Q1 fiscal 2027 earnings release is scheduled for May 20, 2026. Low importance assigned as the announcement of an earnings date typically results in ~1% price impact, scheduled.
5/20/2026, 12:00:00 AM
Hims & Hers Health Inc (HIMS) · Earnings Release
First quarter 2026 financial results and conference call on May 11, 2026, with high importance estimated due to potential market impact of earnings guidance, scheduled.
5/11/2026, 12:00:00 AM
Caris Life Sciences Inc (CAI) · Earnings Release
First quarter 2026 financial results on May 7, 2026, to be released after market close; significant price impact expected based on recent growth trends scheduled.
5/7/2026, 12:00:00 AM
Natera Inc (NTRA) · Earnings Release
Natera is expected to announce its Q1 2026 financial results scheduled. Scheduled earnings releases are key volatility events with an estimated 5% impact.
5/7/2026, 12:00:00 AM
Tempus AI Inc (TEM) · Earnings Release
First quarter 2026 financial results and business update scheduled for May 5, 2026; high impact from potential 10% price volatility expected.
5/5/2026, 12:00:00 AM
BioNTech SE (BNTX) · Earnings Release
BioNTech will report first-quarter 2026 financial results and provide a corporate update on 2026-05-05; given the sharp March 2026 volatility after guidance and leadership news, this update is likely to be closely watched and could move shares materially, expected.
5/5/2026, 12:00:00 AM